These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15790533)

  • 21. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-stranded DNA stimulates the fibrillation of alpha-synuclein in vitro and is associated with the mature fibrils: an electron microscopy study.
    Cherny D; Hoyer W; Subramaniam V; Jovin TM
    J Mol Biol; 2004 Dec; 344(4):929-38. PubMed ID: 15544803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation.
    Ferreon AC; Deniz AA
    Biochemistry; 2007 Apr; 46(15):4499-509. PubMed ID: 17378587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes.
    Munishkina LA; Phelan C; Uversky VN; Fink AL
    Biochemistry; 2003 Mar; 42(9):2720-30. PubMed ID: 12614167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic effects of alpha-synuclein aggregation.
    Lundvig D; Lindersson E; Jensen PH
    Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.
    Murray IV; Giasson BI; Quinn SM; Koppaka V; Axelsen PH; Ischiropoulos H; Trojanowski JQ; Lee VM
    Biochemistry; 2003 Jul; 42(28):8530-40. PubMed ID: 12859200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.
    Dedmon MM; Lindorff-Larsen K; Christodoulou J; Vendruscolo M; Dobson CM
    J Am Chem Soc; 2005 Jan; 127(2):476-7. PubMed ID: 15643843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
    Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural determinants of PLD2 inhibition by alpha-synuclein.
    Payton JE; Perrin RJ; Woods WS; George JM
    J Mol Biol; 2004 Apr; 337(4):1001-9. PubMed ID: 15033366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein.
    Yamin G; Glaser CB; Uversky VN; Fink AL
    J Biol Chem; 2003 Jul; 278(30):27630-5. PubMed ID: 12754258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.
    Uversky VN
    J Biomol Struct Dyn; 2003 Oct; 21(2):211-34. PubMed ID: 12956606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
    Uversky VN; Li J; Souillac P; Millett IS; Doniach S; Jakes R; Goedert M; Fink AL
    J Biol Chem; 2002 Apr; 277(14):11970-8. PubMed ID: 11812782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
    Kong B; Chae Y; Lee K
    Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
    Kim TD; Choi E; Rhim H; Paik SR; Yang CH
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethylamine-N-oxide-induced folding of alpha-synuclein.
    Uversky VN; Li J; Fink AL
    FEBS Lett; 2001 Nov; 509(1):31-5. PubMed ID: 11734201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles.
    Bisaglia M; Tessari I; Pinato L; Bellanda M; Giraudo S; Fasano M; Bergantino E; Bubacco L; Mammi S
    Biochemistry; 2005 Jan; 44(1):329-39. PubMed ID: 15628875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C; Danzer KM; Hengerer B; Gillardon F
    Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-sheet structure formation of proteins in solid state as revealed by circular dichroism spectroscopy.
    Hu HY; Li Q; Cheng HC; Du HN
    Biopolymers; 2001; 62(1):15-21. PubMed ID: 11135188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
    Lee D; Paik SR; Choi KY
    FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.